once-weekly semaglutide in adults with overweight or obesity GLP-1 agonists for weight loss:

Reaching your goal weight on Mounjaro or Zepbound isnt the finish lineits the beginning of a whole new phase

In-clinic programs generally land above the online equivalents because visits come with the package

On its own, the body makes about half the creatine it needs and gets the other half from food

In a study by Kanoni et al., MASLD-obese patients also displayed a significant reduction in erythrocytic SOD activity as compared to a control group (Kanoni et al

For patients with obesity and liver disease or obstructive sleep apnoea, tirzepatide was the recommended OMM

calculated the risk to be 4.8/10,000 in groups taking GLP-1 RAs compared to 4.6/10,000 in the control groups, failing to show a statistically significant difference in aspiration or other complications between the two groups (Chang et al